1263420-05-8

Basic information

• Product Name: 3-carbamoyl-4-(2-methylcyclohexylamino)pyrrolo[1,2-b]pyridazine-7-carboxylic acid
• Synonyms: 3-carbamoyl-4-(2-methylcyclohexylamino)pyrrolo[1,2-b]pyridazine-7-carboxylic acid
• CAS NO: 1263420-05-8
• Molecular Weight: 316.36
• Mol File: 1263420-05-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-carbamoyl-4-(2-methylcyclohexylamino)pyrrolo[1,2-b]pyridazine-7-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-carbamoyl-4-(2-methylcyclohexylamino)pyrrolo[1,2-b]pyridazine-7-carboxylic acid(1263420-05-8)
• EPA Substance Registry System: 3-carbamoyl-4-(2-methylcyclohexylamino)pyrrolo[1,2-b]pyridazine-7-carboxylic acid(1263420-05-8)

Safety Data

• Hazardous Substances Data: 1263420-05-8(Hazardous Substances Data)

Upstream product

• 2199-43-1 ethyl 1H-pyrrole-2-carboxylate 
• 1263420-04-7 ethyl 3-cyano-4-(2-methylcyclohexylamino)pyrrolo[1,2-b]pyridazine-7-carboxylate 
• 1263420-03-6 ethyl 4-chloro-3-cyanopyrrolo[1,2-b]pyridazine-7-carboxylate 
• 952569-58-3 5-(ethoxycarbonyl)-1H-pyrrole-2-carboxylic acid 
• 779345-31-2 3-cyano-4-hydroxy-pyrrolo[1,2-b]pyridazine-7-carboxylic acid ethyl ester 
• 7126-50-3 ethyl 5-formyl-1H-pyrrole-2-carboxylate 

Downstream Products

• 1263420-06-9 tert-butyl 3-carbamoyl-4-(2-methylcyclohexylamino)pyrrolo[1,2-b]pyridazin-7-ylcarbamate 
• 1263419-68-6 4-(2-methylcyclohexylamino)pyrrolo[1,2-b]pyridazine-3,7-dicarboxamide 
• 1263419-08-4 4-(2-methylcyclohexylamino)-7-(2,2,2-trifluoroacetamido)pyrrolo[1,2-b]pyridazine-3-carboxamide 

Relevant articles and documents

PYRROLO [1, 2-B] PYRIDAZINE DERIVATIVES AS JANUS KINASE INHIBITORS

The invention provides compounds of formula l: ( I ) or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for suppressing an immune response or treating cancer or a hematologic malignancy using compounds of formula I.